In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players.
Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. I also provide commentary on recent market developments and offer some helpful tips for interpreting the figures.
Comments